Tag : CRDMO

Clinical Research, Pharma & Healthcare Financing

WuXi Biologics, Vertex Sign License for T-cell Engager

PR NewswireFebruary 3, 2026February 4, 2026

by PR NewswireFebruary 3, 2026February 4, 2026051

WuXi Biologics (2269. HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that it has signed a license and research service...

Healthcare Infrastructure, Operations & Supply Chain

WuXi Biologics Earns CDP Climate Change Leadership Recognition

PR NewswireApril 22, 2025August 1, 2025

by PR NewswireApril 22, 2025August 1, 20250162

WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced it has been recognized by CDP, the world’s...